Підписатись
Valentyn Maslovskyi Валентин Масловський
Valentyn Maslovskyi Валентин Масловський
Professor, Internal Med. dept. 3, National Pirogov Memorial Medical University, Vinnytsya
Підтверджена електронна адреса в vnmu.edu.ua - Домашня сторінка
Назва
Посилання
Посилання
Рік
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
RD Lopes, G Heizer, R Aronson, et al.
N Engl J Med doi: 10.1056/NEJMoa1817083 380 (16), 1509-1524, 2019
12332019
Rivaroxaban in Peripheral Artery Disease after Revascularization
MP Bonaca, RM Bauersachs, SS Anand, et al.
N Engl J Med 382, 1994-2004, 2020
9012020
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
WR Hiatt, FGR Fowkes, G Heizer, et al., ...
The New England Journal of Medicine, 32-40, 2017
7122017
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
SE Nissen, AM Lincoff, D Brennan, et al.
NEW ENGLAND JOURNAL OF MEDICINE, 2023
6032023
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
AT Cohen, RA Harrington, SZ Goldhaber, et al., ...
The New England Journal of Medicine, 534-544, 2016
5312016
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
PG Steg, DL Bhatt, T Simon, et al.
New England Journal of Medicine, Pages: 1309-1320, 2019
3752019
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
AC Spyropoulos, W Ageno, GW Albers, et al.
N Engl J Med. DOI: 10.1056/NEJMoa1805090 379 (12), 1118-1127, 2018
2892018
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo …
DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...
The Lancet 394 (10204), 1169-1180, 2019
2192019
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD
GM Chertow, PE Pergola, YMK Farag, et al.
NEW ENGLAND JOURNAL OF MEDICINE 384 (17), 1589-1600, 2021
2082021
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease
WS Jones, I Baumgartner, WR Hiatt, et al.
Circulation, 241-250, 2016
1342016
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
RJ Mentz, J Garg, FW Rockhold, et. al.
NEW ENGLAND JOURNAL OF MEDICINE 389 (11), 975-986, 2023
1282023
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective …
S Windecker, RD Lopes, T Massaro, et al.
Circulation, 1921–1932, 2019
992019
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill …
CM Gibson, G Chi, R Halaby, et al.
Circulation, 648-655, 2017
732017
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial
CM Gibson, R Halaby, S Korjian, et al.
American Heart Journal, 93-100, 2017
582017
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial
RM Bauersachs, M Szarek, M Brodmann, et. al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 78 (4), 317-326, 2021
562021
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization
I Baumgartner, L Norgren, FGR Fowkes, et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 72 (14), Pages: 1563-1572, 2018
512018
Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance
PM Ridker, L Lei, MJ Louie, et al.
Circulation 149, 28–35, 2024
502024
Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy
CM Gibson, S Korjian, G Chi, et al.
J Am Heart Assoc., 2017
492017
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
JS Berger, BL Abramson, RD Lopes, et al.
Vascular Medicine, 523-530, 2018
432018
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial
L Norgren, MR Patel, WR Hiatt, et al.
European Journal of Vascular end Endovascular Surgery, Pages 109–117, 2018
422018
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20